Clinical Trial Update: Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating docetaxel, epirubicin, and cyclophosphamide with or without trastuzumab in women with locally advanced, surgically resectabl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Docetaxel (Taxotere) (docetaxel)
• Epirubicin (epirubicin)
• Trastuzumab (Herceptin) (trastuzumab)

Snippet

Sponsor: Technical University of Munich | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN